CYNO Cynosure - Class A (MM)

WESTFORD, Mass., June 3 /PRNewswire-FirstCall/ -- Cynosure, Inc. (NASDAQ:CYNO), a leading developer and manufacturer of a broad array of light-based aesthetic treatment systems, today announced that President and Chief Executive Officer Michael Davin and Chief Financial Officer Timothy Baker will discuss the company's business outlook, growth strategy and recent financial results at the following investor conferences this month: -- On Thursday, June 12, the company will present at the 7th Annual Needham & Company Biotechnology and Medical Technology Conference in New York City. The presentation is scheduled to begin at 10:00 a.m. ET. -- On Wednesday, June 25, Cynosure will present at the Jefferies 2nd Annual Healthcare Conference in New York City. The presentation is scheduled to begin at 3:45 p.m. ET. Investors interested in listening to the live webcasts of these presentations should log on to the "Investor Relations" section of Cynosure's website, http://www.cynosure.com/, and click on the link labeled "Events." The presentations also will be archived on the company's website. About Cynosure, Inc. Cynosure, Inc. develops and markets aesthetic treatment systems that are used by physicians and other practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular lesions, rejuvenate skin through the treatment of shallow vascular and pigmented lesions, laser lipolysis and temporarily reduce the appearance of cellulite. Cynosure's products include a broad range of laser and other light-based energy sources, including Alexandrite, pulsed dye, Nd:YAG and diode lasers, as well as intense pulsed light. Cynosure was founded in 1991. For corporate or product information, contact Cynosure at 800-886-2966, or visit http://www.cynosure.com/. DATASOURCE: Cynosure, Inc. CONTACT: Scott Solomon, Vice President of Sharon Merrill Associates, Inc., +1-617-542-5300, , for Cynosure, Inc. Web site: http://www.cynosure.com/

Copyright